CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYCR), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, today announced that St. Louis University and Eastern Virginia Medical School have begun participation as new sites in CytoCore’s current e2 Collector™ clinical trial.
